TLSA insider trading
NasdaqCM HealthcareTiziana Life Sciences Ltd — scored insider trade history from SEC Form 4 filings, parsed and contextualised by FilingIQ.
About Tiziana Life Sciences Ltd
Tiziana Life Sciences Ltd, together with its subsidiaries, engages in the research and development of therapies for neurodegenerative and neuroinflammatory diseases in the United Kingdom and internationally. It develops Foralumab TZLS-401, a human anti-CD3 monoclonal antibody, which is Phase II clinical trial for the treatment of non-active secondary progressive multiple sclerosis, Alzheimer's disease, multi system atrophy, and amyotrophic lateral sclerosis; and TZLS-501, a human anti-IL-6R monoclonal antibody for the treatment of autoimmune and inflammatory diseases. The company is headquartered in London, the United Kingdom.
Company website: www.tizianalifesciences.com
TLSA insider activity at a glance
FilingIQ has scored 3 insider transactions for TLSA since Jun 12, 2026. The most recent filing in our index is dated Aug 3, 2026.
Across the full history, 1 open-market purchases
and 0 open-market sales
were filed under transaction codes P and S respectively. Compensatory share awards
(code A) and option exercises (code M) are tracked separately and not counted here.
The average FilingIQ composite score on TLSA insider trades is 72.0/100, produced by FilingIQ's multi-factor Form 4 model. Model framework documented at methodology.
Latest TLSA Form 4 filings
Most recent disclosures. Sign up to filter by score, transaction code, or insider role.
Other Healthcare tickers with recent insider activity
Frequently asked
- How many insider trades does FilingIQ track for TLSA?
- FilingIQ tracks 3 Form 4 insider transactions for TLSA (Tiziana Life Sciences Ltd), covering filings from Jun 12, 2026 onwards. 3 of those were filed in the last 90 days.
- Are TLSA insiders net buyers or net sellers?
- Across the full Form 4 history for TLSA, 1 transactions (33%) were open-market purchases and 0 (0%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
- Where does TLSA insider data come from?
- Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.
- What sector is TLSA in?
- Tiziana Life Sciences Ltd (TLSA) is classified in the Healthcare sector, specifically Biotechnology, with a current market capitalisation of $162.89M.
Methodology & sources
Every TLSA insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). The FilingIQ composite score is documented in full on the team page and algo disclosure. Not investment advice; see disclaimer.